Total Funding
44
51
Total FundingVenture - Series Unknown raised
Growth Score 44 in past quarter
-5 pts
Heat Score 51 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
101738
Horus Pharma is a pharmaceutical company that focuses around ocular pathology and peri-surgery.
- Martine Claret: President and Founder
- Claude Claret: General manager, CEO, and FounderPast Role: Allergan, Marketing Director
About the Company
Horus Pharma is a French pharmaceutical company specialized in ophthalmology and dermatology. Created in 2003 by Martine and Claude Claret in Saint-Laurent du Var near Nice. Horus Pharma is an independent and innovative laboratory that markets over 30 specialties dedicated to the eye health and comfort.